Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response ; volume:21 ; number:1 ; day:14 ; month:6 ; year:2023 ; pages:1-15 ; date:12.2023
BMC medicine ; 21, Heft 1 (14.6.2023), 1-15, 12.2023
- Urheber
-
Filippini, Federica
Giacomelli, Mauro
Bazzani, Chiara
Fredi, Micaela
Semeraro, Paolo
Tomasi, Cesare
Franceschini, Franco
Caruso, Arnaldo
Cavazzana, Ilaria
Giagulli, Cinzia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-023-02868-w
- URN
-
urn:nbn:de:101:1-2023092012210918077882
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Filippini, Federica
- Giacomelli, Mauro
- Bazzani, Chiara
- Fredi, Micaela
- Semeraro, Paolo
- Tomasi, Cesare
- Franceschini, Franco
- Caruso, Arnaldo
- Cavazzana, Ilaria
- Giagulli, Cinzia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Importance of NK Cells in Cellular and Humoral Responses Triggered by Pneumococcus Vaccination
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Importance of NK Cells in Cellular and Humoral Responses Triggered by Pneumococcus Vaccination
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Importance of NK Cells in Cellular and Humoral Responses Triggered by Pneumococcus Vaccination
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection